Lappe Mark Insider Trading -- Recent SEC Form 4 Transactions
Lappe Mark (CIK 1366074) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-28). Recent activity: Buy INBX (3,324 shares), Buy INBX (2,176 shares), Buy INBX (1,500 shares), Buy INBX (3,000 shares), Buy INBX (5,895 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-28 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 3,324 | $328,630 |
| 2026-09-28 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 2,176 | $216,727 |
| 2026-09-28 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 1,500 | $148,320 |
| 2026-09-28 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 3,000 | $305,106 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 5,895 | $585,343 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 6,605 | $664,719 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 1,100 | $117,836 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 500 | $54,118 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 1,219 | $136,382 |
| 2026-09-08 | Inhibrx Biosciences, Inc. (INBX) | Chief Executive Officer | Buy | 9,681 | $1.1M |
Source: SEC Form 4 filings · as of 2026-09-28